Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Debnath

Showing results (201-210 of 231) with videos related to

Pageof 24
Sort By:
Journal of Medicinal Chemistry|December 17, 2021
Correction to "HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites"Natalie Losada, Francesc X Ruiz, Francesca Curreli, et al.
Journal of Medicinal Chemistry|December 31, 2010
Design, synthesis, and biological activity of novel 5-((arylfuran/1H-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-ones as HIV-1 fusion inhibitors targeting gp41Shibo Jiang, Srinivasa R Tala, Hong Lu, et al.
Chemmedchem|September 13, 2022
Design, Synthesis, and Antiviral Activity of the Thiazole Positional Isomers of a Potent HIV-1 Entry Inhibitor NBD-14270Alexander V Kurkin, Francesca Curreli, Ildar R Iusupov, et al.
Lancet (London, England)|March 27, 2004
Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitorsShuwen Liu, Gengfu Xiao, Yibang Chen, et al.
Journal of Medicinal Chemistry|February 8, 2020
Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral EvaluationFrancesca Curreli, Shahad Ahmed, Sofia M Benedict Victor, et al.
Bioorganic & Medicinal Chemistry|January 18, 2021
Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitorsFrancesca Curreli, Shahad Ahmed, Sofia M Benedict Victor, et al.
Journal of Hazardous Materials|December 1, 2020
"Carbon nano tubes functionalized with novel functional group- amido-amine for sorption of actinides"A K Singh Deb, S Pahan, K Dasgupta, et al.
Spine Deformity|November 17, 2021
Correction to: Long-term outcome after surgical treatment of Scheuermann's Kyphosis (SK)Ujjwal K Debnath, Nasir A Quraishi, Michael J H McCarthy, et al.
Andrologia|January 19, 2010
Clinical evaluation of spermatogenic activity of processed Shilajit in oligospermiaT K Biswas, S Pandit, S Mondal, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2009
ADS-J1 inhibits human immunodeficiency virus type 1 entry by interacting with the gp41 pocket region and blocking fusion-active gp41 core formationHongtao Wang, Zhi Qi, Angi Guo, et al.
Pageof 24

Showing results (201-210 of 231) with videos related to

Sort By:
Pageof 24
Journal of Medicinal Chemistry|December 17, 2021
Correction to "HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites"Natalie Losada, Francesc X Ruiz, Francesca Curreli, et al.
Journal of Medicinal Chemistry|December 31, 2010
Design, synthesis, and biological activity of novel 5-((arylfuran/1H-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-ones as HIV-1 fusion inhibitors targeting gp41Shibo Jiang, Srinivasa R Tala, Hong Lu, et al.
Chemmedchem|September 13, 2022
Design, Synthesis, and Antiviral Activity of the Thiazole Positional Isomers of a Potent HIV-1 Entry Inhibitor NBD-14270Alexander V Kurkin, Francesca Curreli, Ildar R Iusupov, et al.
Lancet (London, England)|March 27, 2004
Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitorsShuwen Liu, Gengfu Xiao, Yibang Chen, et al.
Journal of Medicinal Chemistry|February 8, 2020
Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral EvaluationFrancesca Curreli, Shahad Ahmed, Sofia M Benedict Victor, et al.
Bioorganic & Medicinal Chemistry|January 18, 2021
Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitorsFrancesca Curreli, Shahad Ahmed, Sofia M Benedict Victor, et al.
Journal of Hazardous Materials|December 1, 2020
"Carbon nano tubes functionalized with novel functional group- amido-amine for sorption of actinides"A K Singh Deb, S Pahan, K Dasgupta, et al.
Spine Deformity|November 17, 2021
Correction to: Long-term outcome after surgical treatment of Scheuermann's Kyphosis (SK)Ujjwal K Debnath, Nasir A Quraishi, Michael J H McCarthy, et al.
Andrologia|January 19, 2010
Clinical evaluation of spermatogenic activity of processed Shilajit in oligospermiaT K Biswas, S Pandit, S Mondal, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2009
ADS-J1 inhibits human immunodeficiency virus type 1 entry by interacting with the gp41 pocket region and blocking fusion-active gp41 core formationHongtao Wang, Zhi Qi, Angi Guo, et al.
Pageof 24